In section Releases

Rigel Pharmaceuticals Schedules September Investor Circuit

Rigel Pharmaceuticals’ chief financial officer Dean Schorno will headline a series of investor conferences this month, targeting three major industry gatherings in New York. The biotechnology firm aims to bolster its market visibility through a mix of one-on-one sessions and formal company presentations scheduled across mid-September.

By Money Talk·September 2, 2026·2 min read·504 reads

Rigel Pharmaceuticals Schedules September Investor Circuit

The tour begins September 9 at the Citi Biopharma Back to School Conference, followed by the Cantor Global Healthcare Conference on September 10, where Schorno is set to deliver a company overview at 11:30 a.m. ET. The series concludes on September 15 at the H.C. Wainwright 28th Annual Global Investment Conference, featuring a 10:00 a.m. ET presentation.

Investors can access live webcasts and archived recordings for the Cantor and H.C. Wainwright sessions via the company’s investor relations portal. Based in South San Francisco, Rigel continues its focus on developing therapies for hematologic disorders and oncology, maintaining its presence in the commercial-stage biotech sector since its founding in 1996.

Rigel Pharmaceuticals Schedules September Investor Circuit

Comments (0)